[1]
V. Riabukha, “Chronic inflammation asociated with obesity, diabetes mellitus type 2 and cardiovascular risk as a target for therapeutic interventions. Part 1”, МСЗ, vol. 81, no. 4, pp. 44–50, Feb. 2020.